Cantoni Therapeutics
PrivateLast Round
Seed
Sep 16, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cantoni Therapeutics is a biotechnology company developing small molecule inhibitors of nicotinamide N-methyltransferase (NNMT) for the treatment of obesity and its comorbidities.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cantoni Therapeutics Comparables
Compare Cantoni Therapeutics with similar companies based on industry and business-model similarity.
Cantoni Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 16, 2025 | ||||
| Pre Seed | Dec 1, 2022 |
Cantoni Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brabantse Ontwikkelings Maatschappij | Seed |
| Libertatis Ergo Holding | Pre Seed, Seed |
| Brabant Startup Fonds | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 16, 2025
Led by Libertatis Ergo Holding with participation from Brabant Startup Fonds and Brabantse Ontwikkelings Maatschappij.
- Sep 19, 2024
Grew 75% QoQ, from 4 to 7 employees.
Cantoni Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cantoni Therapeutics's valuation, stock price, and market status.